Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
SOLENO THERAPEUTICS INCListing unverified | Sell | $26.3M | SEC | ||
SOLENO THERAPEUTICS INCListing unverified | Sell | $23.5M | SEC | ||
SOLENO THERAPEUTICS INCListing unverified | Sell | $74.6M | Unusual size | SEC | |
SOLENO THERAPEUTICS INCListing unverified | Sell | $35.9M | SEC | ||
SOLENO THERAPEUTICS INCListing unverified | Sell | $15.9M | SEC | ||
SOLENO THERAPEUTICS INCListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
SOLENO THERAPEUTICS INCListing unverified | Other | $13M | SEC | ||
SOLENO THERAPEUTICS INCListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
SOLENO THERAPEUTICS INCListing unverified | Other | $5.6M | SEC | ||
Terns Pharmaceuticals, Inc.Listing unverified | Buy | $5.5M | conv 50ClusterFirst in 12mo | SEC |